In summary, we constructed a comprehensive ceRNA network characterized by a tumor invasion phenotype and identified a PVT1/DUSP13 axis featured with lipid regulatory potential, immune properties, and abnormal methylation states in patients with HCC and MVI. This evidence concerns the gene DUSP13A and hepatocellular carcinoma.